BMI OrganBank

BMI OrganBank is a medical technology company focused on improving the viability and availability of donor organs for transplantation. The company develops advanced ex-vivo organ perfusion systems that maintain organs in a physiological state, moving beyond the limitations of traditional static cold storage. Their flagship technology is designed to preserve, assess, and potentially recondition organs such as kidneys, thereby increasing the success rate of transplants and expanding the donor pool. By providing a controlled environment for organs outside the body, BMI OrganBank aims to reduce the incidence of delayed graft function and improve long-term patient outcomes. The company's platform is built on proprietary perfusion techniques that allow for real-time monitoring and optimization of organ health prior to surgery.